Drug companies will soon be required to include the list price of medications that cost more than $35 and are sold through Medicare or Medicaid in its television advertisements thanks to a federal rule finalized May 8.
Now industry observers are waiting for the other shoe to drop: namely, a lawsuit to stop the rule in its tracks. The lobbyist group representing brand pharmaceutical companies insinuated it would sue when the Centers for Medicare & Medicaid Services first proposed the rule in October.
The Pharmaceutical Research and Manufacturers of America said it’s still reviewing the rule and wouldn’t comment on...
For more stories, analysis and expertiseOR Request Trial
(Adds effective date of the final rule in the last paragraph.)